Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis

被引:0
作者
Christmas, NJ [1 ]
Smiddy, WE [1 ]
机构
[1] UNIV MIAMI,SCH MED,BASCOM PALMER EYE INST,DEPT OPHTHALMOL,MIAMI,FL 33101
来源
OPHTHALMIC SURGERY AND LASERS | 1996年 / 27卷 / 12期
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
BACKGROUND AND OBJECTIVE: To investigate the efficacy of pars plana vitrectomy and oral fluconazole without injection of intravitreal antimycotic agents in the treatment of vitritis resulting from Candida endophthalmitis. PATIENTS AND METHODS: Six eyes of five patients with suspected Candida endophthalmitis were treated with pars plana vitrectomy and systemic fluconazole for at least 3 weeks. Patients were observed postoperatively for at least 4 months. RESULTS: Clinical signs of infection cleared and visual acuity improved postoperatively in all six cases. One recurrent case was attributed to a retained indwelling venous catheter. CONCLUSIONS: Treatment of advanced endogenous Candida endophthalmitis with vitrectomy and systemic fluconazole offers an effective alternative to management with intravitreal amphotericin B in selected cases.
引用
收藏
页码:1012 / 1018
页数:7
相关论文
共 33 条
  • [1] TOXICITY OF INTRAVITREAL INJECTION OF AMPHOTERICIN-B
    AXELROD, AJ
    PEYMAN, GA
    APPLE, DJ
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1973, 76 (04) : 578 - 583
  • [3] BROD RD, 1990, OPHTHALMOLOGY, V97, P666, DOI 10.1016/S0161-6420(90)32547-2
  • [4] BROD RD, 1991, CURR OPIN OPHTHALMOL, V2, P306
  • [5] BROD RD, 1994, DUANES CLIN OPHTHALM, V6, P14
  • [6] CHUNG Y, 1994, CHIN MED J TAIPEI, V53, P239
  • [7] CLINICAL PHARMACOKINETICS OF FLUCONAZOLE
    DEBRUYNE, D
    RYCKELYNCK, JP
    [J]. CLINICAL PHARMACOKINETICS, 1993, 24 (01) : 10 - 27
  • [8] DESPRES E, 1990, B SOC OPHTHALMOL FRA, V1, P105
  • [9] DONAHUE SP, 1994, OPHTHALMOLOGY, V101, P1302, DOI 10.1016/S0161-6420(94)31175-4
  • [10] FULLER SG, 1991, ANTIMICROB AGENTS CH, V35, P288